UG
United-Guardian·NASDAQ
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 3
Bearish signal 1
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
High Cash/net Profit Ratio
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About UG
United-Guardian, Inc.
A manufacturer of cosmetic ingredients, pharmaceuticals, medical and health care products, and specialty chemicals
230 Marcus Blvd., Hauppauge, NY 11788
--
United-Guardian, Inc., a Delaware corporation, was founded in New York in 1942. Through the Guardian Laboratories division, the company manufactures and sells cosmetic ingredients, pharmaceutical products, medical lubricants and sexual health ingredients. The company conducts various research and development activities. The company's R&D department focuses on developing new and unique cosmetic ingredients. The company uses natural and environmentally friendly raw materials to develop new products, which is a priority for many of the company's cosmetic customers. The company's R&D department also transforms, refines and expands the use of existing products, with the goal of further expanding the market for which its products are applied.
Company Financials
EPS
UG has released its 2025 Q3 earnings. EPS was reported at 0.06, versus the expected 0, beating expectations. The chart below visualizes how UG has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
UG has released its 2025 Q3 earnings report, with revenue of 2.26M, reflecting a YoY change of -26.01%, and net profit of 268.44K, showing a YoY change of -68.98%. The Sankey diagram below clearly presents UG's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
